Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Inv. presentation
Quarterly results
Appointed director
CC transcript
Elevance Health, Inc. (ANTM) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 8-K Quarterly results
10/05/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "BYLAWS OF"
09/29/2023 10-Q/A Quarterly Report for the period ended June 30, 2023 [amend]
08/08/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Offer Letter, between Mark Kaye and Elevance Health, Inc",
"Elevance Health Announces John Gallina to Retire as CFO"
07/21/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/19/2023 8-K Quarterly results
Docs: "ELEVANCE HEALTH REPORTS SECOND QUARTER 2023 RESULTS"
06/13/2023 8-K Regulation FD Disclosure  Interactive Data
05/11/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
04/19/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/19/2023 8-K Quarterly results
03/31/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/31/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/22/2023 8-K Regulation FD Disclosure  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
02/22/2023 8-K Quarterly results
02/14/2023 SC 13G PRICE T ROWE ASSOCIATES INC reports a 5.3% stake in ELEVANCE HEALTH INC
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9% stake in Elevance Health Inc.
02/08/2023 8-K Quarterly results
01/30/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
01/30/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
01/27/2023 SC 13G/A BlackRock Inc. reports a 9% stake in Elevance Health, Inc.
01/25/2023 8-K Quarterly results
Docs: "ELEVANCE HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS"
11/15/2022 SC 13G Elevance Health, Inc. reports a 10% stake in GoHealth, Inc.
11/04/2022 8-K Quarterly results
10/27/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
10/26/2022 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
10/26/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
10/25/2022 8-K Quarterly results
10/19/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/19/2022 8-K Quarterly results
07/20/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/20/2022 8-K Quarterly results
06/28/2022 8-K Quarterly results
06/24/2022 11-K Form 11-K - Annual report of employee stock purchase, savings and similar plans:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy